Period Period Low Period High Performance
1-Month $36.59 +14.48% on 11/09/17 $42.68 -1.85% on 11/29/17 +2.33 (+5.89%)
3-Month $35.76 +17.14% on 10/17/17 $42.68 -1.85% on 11/29/17 +2.97 (+7.63%)
52-Week $35.76 +17.14% on 10/17/17 $46.80 -10.49% on 06/22/17 +3.38 (+8.78%)

Publicly-traded company Hologic, Inc. (NASDAQ:HOLX) had a closing price of $41.89 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $45.14, this means that the stock is underpriced by 7.2%.

In the past 52 weeks the company’s stock price has moved within the range of $35.76 to $46.80.

This particular stock’s 5-day moving average is 41.72, its 20-day moving average is 40.46 and its 100-day moving average is 39.19. Hologic, Inc. (HOLX) currently has 275680 shares outstanding, which means that its market capitalization is $11.70B.




The Details: Hologic, Inc. (NASDAQ:HOLX) Financial Health

There are numerous indicators we can use to give us a better idea about a public company’s financial health. For instance, we can check out the profit margin, which tells us about how much of a company’s net sales it keeps as earnings. We find this figure by dividing net income by net sales. HOLX currently has a profit margin of 24.70%.

It can also be helpful to look at a public company’s operating margin, which shows us how much profit the company retains after taking depreciation and operating expenses into account. Hologic, Inc. (HOLX) has an operating margin of 44.70%.

It is also smart to find out what a company’s Return on Assets is. This percentage tells us how well a company is making use of its net assets to generate a profit. The lower the percentage, the worse the company does with its available assets. At the moment, Hologic, Inc. Return on Assets is 9.40%.


What Does Wall Street Say about Company?

When considering a new stock purchase, a lot of investors find out how Wall Street analysts feel about the company before they buy in. You can do this by looking for the average analyst rating on the company’s stock. At the moment, the average analyst rating for HOLX is Moderate Buy. Out of 15 total analysts who were surveyed, 1 rated it a Moderate Buy, 5 rated it hold, and 9 rated it a Strong Buy.

Three months ago, on the other hand, the average analyst rating for Hologic, Inc. (HOLX) was a Moderate Buy – from a survey of 17 analysts. Of the analysts who provided ratings, 6 rated the company a Hold, 1 rated it a Moderate Buy, and 10 rated it a Strong Buy.


Understanding Profitability at Hologic, Inc. (NASDAQ:HOLX)

Having a look at a company’s recent Earnings per Share (EPS) performance is a useful way of understanding its profitability. In the most recent financial results released by Hologic, Inc., for the quarter ending on 2017-09-30, the company posted EPS of 0.5. The average estimate of Wall Street analysts had projected 0.49.

Wall Street analysts, on average, are forecasting the company’s EPS to be 0.49, compared to 0.52 reported in the same quarter last year. When it comes to net revenue, the average estimate from a total of 14 analysts is 785.27 million – compared to $734.4 million posted in the year-ago period.